HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nan Zhong Selected Research
Nan Zhong Research Topics
Disease
3
Neoplasms (Cancer)
01/2022 - 05/2003
3
Brain Neoplasms (Brain Tumor)
03/2013 - 01/2002
2
Infections
05/2018 - 04/2010
2
Parkinson Disease (Parkinson's Disease)
11/2008 - 05/2005
1
Osteoarthritis
07/2022
1
COVID-19
01/2022
1
Dental Fluorosis
01/2022
1
Carcinogenesis
01/2022
1
Chronic Disease (Chronic Diseases)
06/2021
1
Hypoproteinemia
04/2020
1
Metabolic Bone Diseases (Osteopenia)
04/2020
1
Hyperferritinemia
05/2018
1
Cytopenia
05/2018
1
Fever (Fevers)
05/2018
1
Acute Monocytic Leukemia (Acute Monoblastic Leukemia)
05/2018
1
Splenomegaly
05/2018
1
Inflammation (Inflammations)
03/2011
1
Intellectual Disability (Idiocy)
11/2009
1
Angelman Syndrome (Syndrome, Angelman)
12/2008
1
Prader-Willi Syndrome (Syndrome, Prader-Willi)
12/2008
1
Carcinoma (Carcinomatosis)
05/2003
1
Gliosarcoma
01/2002
1
Glioma (Gliomas)
01/2002
Drug/Important Bio-Agent (IBA)
4
Fluorides
IBA
07/2022 - 04/2020
3
Proteins (Proteins, Gene)
FDA Link
01/2022 - 11/2008
2
Chromatin
IBA
03/2013 - 11/2012
1
Drinking Water
IBA
01/2022
1
Neutralizing Antibodies
IBA
01/2022
1
Competitive Endogenous RNA
IBA
01/2022
1
Biomarkers (Surrogate Marker)
IBA
01/2022
1
Indicators and Reagents (Reagents)
IBA
01/2022
1
Ferritins (Ferritin)
IBA
04/2020
1
Cytarabine (Cytosar-U)
FDA Link
Generic
05/2018
1
Interleukin-2 (IL2)
IBA
05/2018
1
Methylprednisolone
FDA Link
Generic
05/2018
1
Idarubicin (4 Demethoxydaunorubicin)
FDA Link
Generic
05/2018
1
UNC1215
IBA
03/2013
1
Polycomb Repressive Complex 1
IBA
11/2012
1
Histones (Histone)
IBA
11/2012
1
Chemokines
IBA
03/2011
1
Polyproteins
IBA
04/2010
1
Protein Deglycase DJ-1
IBA
05/2005
Therapy/Procedure
2
Ligation
11/2009 - 12/2008
2
Synchrotrons
05/2003 - 01/2002
2
Radiotherapy
05/2003 - 01/2002
1
Drug Therapy (Chemotherapy)
05/2018
1
Induction Chemotherapy
05/2018
1
Therapeutics
08/2003
1
Hair Removal (Depilation)
05/2003